Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
Ping Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Journal for Immunotherapy of Cancer
|
July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors
Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
Cancer Research Communications
|
December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma
Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
JCO Oncology Advances
|
May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021
Margaret von Mehren, John M Kane, Marilyn M Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in Sarcoma
Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M Kane, Mark Agulnik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma
Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.
Nature Communications
|
June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Mrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
Ping Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Journal for Immunotherapy of Cancer
|
July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors
Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
Cancer Research Communications
|
December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma
Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
JCO Oncology Advances
|
May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021
Margaret von Mehren, John M Kane, Marilyn M Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in Sarcoma
Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M Kane, Mark Agulnik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma
Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.
Nature Communications
|
June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Mrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Page
of 5